Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Courtyard Marriott, Mumbai

Sep 22, 2017 8:00 AM - Sep 23, 2017 6:00 PM

Mumbai C.T.S. No. 215, Andheri Kurla Road, Andheri East 400 059, MH, India

Deciphering the Why, When and How of Risk Based Monitoring

Back to Agenda

Day 2: Session 4: RBM: The Site, CRO and Pharma Perspective

Session Chair(s)

Durga A. Gadgil

Clinical Research Consultant

India

Speaker(s)

Session 4.1: Establishing Operations in RBM: The CRO Perspective

Prasida Dinesh, RPh

Chiltern Clinical Research (I) Pvt. Ltd, India

Associate Director

Abhijit Arun Parab, MS

Session 4.2: Allergan RBM Implementation: Strategy: A Case Study

Abhijit Arun Parab, MS

Allergan, United States

Director - CDM and Programming

Session 4.3: The Critical role of the CRC in transitioning to an RBM model

Sauren Das

Excel Life Sciences Pvt. Ltd., India

Country Head & Director - Operations

Have an account?